AETHLON MEDICAL INC (AEMD) › Operating Cash FlowAETHLON MEDICAL INC (AEMD) — Operating Cash FlowAnnual figures by period end, from SEC filings.2011-03-31: -$1.97M2012-03-31: -$1.84M2013-03-31: -$2.10M2014-03-31: -$2.14M2015-03-31: -$5.05M2016-03-31: -$4.33M2017-03-31: -$3.51M2018-03-31: -$3.91M2019-03-31: -$4.29M2020-03-31: -$5.20M2021-03-31: -$6.76M2022-03-31: -$9.77M2023-03-31: -$10.51M2024-03-31: -$10.13M2025-03-31: -$7.65M2026-03-31: -$7.00M-$7.00M2011-03-31Operating Cash Flow (USD)2026-03-31Period endedOperating Cash FlowChange YoYSource filing2026-03-31-$7.00M—2026-06-10From 2025-04-012025-03-31-$7.65M—2026-06-10From 2024-04-012024-03-31-$10.13M—2025-06-26From 2023-04-012023-03-31-$10.51M—2024-06-27From 2022-04-012022-03-31-$9.77M—2023-06-28From 2021-04-012021-03-31-$6.76M—2022-06-28From 2020-04-012020-03-31-$5.20M—2021-06-24From 2019-04-012019-03-31-$4.29M—2020-06-25From 2018-04-012018-03-31-$3.91M—2019-07-01From 2017-04-012017-03-31-$3.51M—2018-06-08From 2016-04-012016-03-31-$4.33M—2017-06-28From 2015-04-012015-03-31-$5.05M—2016-06-29From 2014-04-012014-03-31-$2.14M—2015-07-13From 2013-04-012013-03-31-$2.10M—2014-07-15From 2012-04-012012-03-31-$1.84M—2013-07-15From 2011-04-012011-03-31-$1.97M—2012-06-29From 2010-04-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)